BABY SPACEROCK
08-21

$UnitedHealth(UNH)$ 

 UNH's potential closing price this week could include:

Speculating on a specific closing price or range for UNH by the end of the week, e.g., "I think it will close above $500," or "Expecting it to dip to $480." Discussing the company's financials, future prospects, or relevant news that might impact its stock price, e.g., "Their Q3 earnings report could be a major factor," or "Regulatory changes are a real concern." Referring to charts, indicators, or patterns to support a price outlook, e.g., "The RSI is oversold, so a bounce is likely," or "It's hitting resistance at this level." Highlighting potential risks or opportunities not explicitly mentioned in the snippet, e.g., "Don't forget about the antitrust probe," or "Their Optum division continues to show strong growth." Expressing personal opinions or observations about market sentiment towards UNH, e.g., "Everyone seems bullish on UNH right now," or "I'm staying away until the regulatory dust settles."Affirming or challenging the premise of the post/article, I respectfully disagree; the risks are too high.

UNH Breakout: Next Target $400?
UnitedHealth continues to jump after the health insurer reaffirmed its full-year 2025 earnings outlook. The company said it continues to expect adjusted earnings of at least $16.00 per share with revenue in the range of $445.5 billion to $448.0 billion. Wall Street currently forecasts earnings of $16.24 per share on revenue near $448.2 billion. ----------- After breaking the key resistance level of $320, is UNH hitting the short term peak? Have you jumped on the wagon with Buffett?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment